Actionable data for precision oncology
Framing trustworthy evidence for exploratory research and clinical diagnostics
Datos Bibliográficos
| ID | 4772913 |
|---|---|
| Autores | Niccolò Tempini (0000-0002-5100-5376, The Alan Turing Institute, autor de correspondencia), Sabina Leonelli (0000-0002-7815-6609, The University of Adelaide) |
| Año | 2021 |
| Volumen | 272 |
| Páginas | 113760 |
| Fecha de publicación | 2021-03-01 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | Social Science & Medicine (JOURNAL) |
| Identificadores de la revista | ISSN: 0277-9536 • E-ISSN: 1873-5347 |
| Editorial | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.socscimed.2021.113760 |
| PMID | 33601250 |
| OpenAlex | W3129298565 |
| Idioma | EN |
| Citas recibidas | 14 |
| Referencias citadas | 36 |
Huge amounts of genomic data produced by researchers around the world undermine data-centred discovery and therapeutic development. This paper considers how researchers make decisions about the actionability of specific datasets and the conditions that allow such data to be trusted. We discuss the case of COSMIC, a leading cancer genomics database which aggregates a large amount of sources. We research what the actionability of cancer data means in different situations of use, contrasting exploratory and diagnostics research. They highlight different questions and concerns upon genomic data use in medical research. At the same time, strategies and justifications pursued to evaluate and re-use can also share important similarities. To explain differences and similarities, we argue for an understanding of actionability and trust in data that depends on the goals and resources within the situation of inquiry, and the social epistemology of standards
Big data · Biobank · Bioinformatics · Biology · Data mining · Data science · Engineering ethics · Exploratory research · Framing (construction · Internet privacy · Social science · Sociology · Trustworthiness · Cancer Genomics and Diagnostics · Computer Science · Ethics in Clinical Research · Genomics and Rare Diseases · Psychology
The Changing Concept of Actionability in Precision Medicine
Living (well) with cancer in the precision era
Actionable predictions
Reconciling data actionability and accountability in global health research
Applying a risk governance approach to examine how professionals perceive the benefits and risks of clinical genomics in Australian healthcare
Sorting out and navigating uncertainty in precision medicine
Is Data Science Transforming Biomedical Research? Evidence, Expertise, and Experiments in Covid-19 Science
Concepts of Actionability in Precision Oncology
Decision‐making as discovery
A precision immuno-oncology turn? Hybridizing cancer genomics and immunotherapy through neoantigens-based adoptive cell therapies
Organizing precision medicine
We know what to do for you, but we can't do it
The Role of Algorithms in Molecular Tumour Boards-Managing the Gap Between Research and Clinic in Precision Medicine
Personalising clinical pathways in a London breast cancer service
How To Be Trustworthy
Data-Centric Biology
Trust in Numbers
Narrating uncertainty
Data-intensive resourcing in healthcare
Genomic research and the cancer clinic
Data curation-research
Beyond full jurisdiction
On being “actionable”
Sequencing through thick and thin
Informing materials
From parts to mechanisms
Trust in standards
Concealment and discovery
Imagined communities
Reordering Life
Orders and Their Others
Continuity, capture, network
Imagined Communities. Reflections on the Origin and Spread of Nationalism
Leviathan and the Air-Pump
Genomic expertise in action
| Obras citantes distintas | 14 |
|---|---|
| Citas por año | 3,5 |
| Intervalo de citas | 2022 - 2026 (5) |
| Velocidad de citación | current |
| Altamente citado | No |
| Tipos de cita | Neutras: 14 |